![IRAK inhibitor 3 etarrestin (ML246) Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid]](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M10672_1621562273.gif?v=1621562275)
Pay in 4 interest-free payments of $33.00 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid]
13-diazapentacyclo[13
3-thiazol-2-ylidene]-2
Vildagliptin has been shown to reduce hyperglycemia in type 2 diabetes mellitus
CAS Number: 681492-22-8
IRAK inhibitor 3 etarrestin (ML246) Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid]IRAK inhibitor 3 is an interleukin 1 (IL I) receptor associated kinase (IRAK) kinase modulator extracted from patent WO2008030579 A2. Product information CAS Number: 1012343 93 9 Molecular Weight: 439. 49 Formula: C21H21N5O4S Chemical Name: 4 ({[3 (3,4 dimethoxyphenyl)imidazo[1,2 b]pyridazin 6 yl]amino}methyl)benzene 1 sulfonamide Smiles: COC1=CC=C(C=C1OC)C1=CN=C2C=CC(NCC3C=CC(=CC=3)S(N)(=O)=O)=NN21 InChiKey: UPFVAHVWLNBVSG UHFFFAOYSA N InChi:
US$ 163.00
US$ 16.32
US$ 35.95
US$ 65.00
US$ 75.00
US$ 55.00